Annual Working Capital
$115.22 M
-$81.91 M-41.55%
31 December 2023
Summary:
Solid Biosciences annual working capital is currently $115.22 million, with the most recent change of -$81.91 million (-41.55%) on 31 December 2023. During the last 3 years, it has fallen by -$19.20 million (-14.29%). SLDB annual working capital is now -42.11% below its all-time high of $199.01 million, reached on 31 December 2021.SLDB Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$156.64 M
-$26.28 M-14.37%
30 September 2024
Summary:
Solid Biosciences quarterly working capital is currently $156.64 million, with the most recent change of -$26.28 million (-14.37%) on 30 September 2024. Over the past year, it has increased by +$24.11 million (+18.19%). SLDB quarterly working capital is now -37.71% below its all-time high of $251.47 million, reached on 31 March 2021.SLDB Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SLDB Working Capital Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -41.5% | +18.2% |
3 y3 years | -14.3% | -27.6% |
5 y5 years | -0.8% | +61.9% |
SLDB Working Capital High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -42.1% | at low | -27.6% | +36.0% |
5 y | 5 years | -42.1% | +69.4% | -37.7% | +1163.5% |
alltime | all time | -42.1% | +248.1% | -37.7% | +1163.5% |
Solid Biosciences Working Capital History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $156.64 M(-14.4%) |
June 2024 | - | $182.92 M(-8.5%) |
Mar 2024 | - | $199.85 M(+73.5%) |
Dec 2023 | $115.22 M(-41.6%) | $115.22 M(-13.1%) |
Sept 2023 | - | $132.53 M(-12.6%) |
June 2023 | - | $151.61 M(-11.0%) |
Mar 2023 | - | $170.31 M(-13.6%) |
Dec 2022 | $197.13 M(-0.9%) | $197.13 M(+51.0%) |
Sept 2022 | - | $130.58 M(-12.2%) |
June 2022 | - | $148.72 M(-15.9%) |
Mar 2022 | - | $176.86 M(-11.1%) |
Dec 2021 | $199.01 M(+48.1%) | $199.01 M(-8.0%) |
Sept 2021 | - | $216.27 M(-7.0%) |
June 2021 | - | $232.53 M(-7.5%) |
Mar 2021 | - | $251.47 M(+87.1%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2020 | $134.42 M(+97.6%) | $134.42 M(+984.3%) |
Sept 2020 | - | $12.40 M(-59.2%) |
June 2020 | - | $30.37 M(-32.6%) |
Mar 2020 | - | $45.02 M(-33.8%) |
Dec 2019 | $68.03 M(-41.4%) | $68.03 M(-29.7%) |
Sept 2019 | - | $96.74 M(+49.6%) |
June 2019 | - | $64.65 M(-25.9%) |
Mar 2019 | - | $87.22 M(-24.9%) |
Dec 2018 | $116.16 M(+95.6%) | $116.16 M(-15.7%) |
Sept 2018 | - | $137.79 M(-11.6%) |
June 2018 | - | $155.79 M(-10.7%) |
Mar 2018 | - | $174.45 M(+193.8%) |
Dec 2017 | $59.39 M(+79.4%) | $59.39 M(+213.1%) |
Sept 2017 | - | $18.97 M(-42.7%) |
Dec 2016 | $33.10 M(-20.8%) | $33.10 M |
Dec 2015 | $41.77 M | - |
FAQ
- What is Solid Biosciences annual working capital?
- What is the all time high annual working capital for Solid Biosciences?
- What is Solid Biosciences annual working capital year-on-year change?
- What is Solid Biosciences quarterly working capital?
- What is the all time high quarterly working capital for Solid Biosciences?
- What is Solid Biosciences quarterly working capital year-on-year change?
What is Solid Biosciences annual working capital?
The current annual working capital of SLDB is $115.22 M
What is the all time high annual working capital for Solid Biosciences?
Solid Biosciences all-time high annual working capital is $199.01 M
What is Solid Biosciences annual working capital year-on-year change?
Over the past year, SLDB annual working capital has changed by -$81.91 M (-41.55%)
What is Solid Biosciences quarterly working capital?
The current quarterly working capital of SLDB is $156.64 M
What is the all time high quarterly working capital for Solid Biosciences?
Solid Biosciences all-time high quarterly working capital is $251.47 M
What is Solid Biosciences quarterly working capital year-on-year change?
Over the past year, SLDB quarterly working capital has changed by +$24.11 M (+18.19%)